IL22 and psoriasis: Through the synthesis of IL-22 and the subsequent STAT3 activation in K5-promotor transgenic mice engineered to overexpress CD147 in epidermal keratinocytes, epidermal CD147 contributes to the pathophysiology of psoriasis [71].